Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tibrolin for Postoperative Inflammation after Third Molar Extraction
NCT05681312Phase 3Recruiting
- Sponsor
- University of Baghdad
- Start
- May 2024
- Primary completion
- Sep 2024
- Modality
- Therapeutic Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of trypsin + bromelain + rutoside in postoperative pain and trismus (2 arms), sponsored by University of Baghdad. Primary endpoints: Postoperative Pain at Day 7, Facial Swelling at Day 7 and 2 more. Started May 2024; status: recruiting.
02
Drugs
trypsin + bromelain + rutoside
03
Conditions
postoperative paintrismus
Beyond the preview
Go deeper on NCT05681312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05681312.